WHO member states agree on draft pandemic treaty to address gaps exposed by COVID-19. Learn what the treaty covers, who’s involved, and what it means globally.
Currently browsing: Future
ASSURE In the News
Should You Keep Rapid Tests for Spring & Summer 2025?
As travel picks up in 2025, rapid COVID-19 tests remain essential for health safety. Learn why keeping home tests like ASSURE-100 is still a smart move.
COVID-19 Trends Around Easter 2025: U.S. Hotspots and Public Health Insights
As Easter 2025 approaches, COVID-19 trends in the U.S. show regional variations. Learn about current hotspots, testing recommendations, and public health guidance.
Novavax COVID-19 Vaccine Shows Lower Reactogenicity Than mRNA
Discover how the Novavax COVID-19 vaccine offers a protein-based alternative with fewer side effects compared to mRNA vaccines, based on recent studies.
Where to Find Reliable COVID-19 Information in April 2025: Trusted Sources and Tools
Discover the most reliable sources for up-to-date COVID-19 information in April 2025, including CDC, WHO, and state health departments, plus trusted rapid testing options.
New Antiviral Stops Long COVID in Mice, Scientists Report
A breakthrough antiviral compound has halted long COVID symptoms in mice, offering new hope for human treatments. Here’s what researchers discovered in 2025.
Next-Gen COVID-19 Vaccines by INOVIO, Ocugen, Pfizer in 2025
Explore the latest COVID-19 vaccines in development by INOVIO, Ocugen, and Pfizer. Learn about new delivery platforms and what’s next in SARS-CoV-2 protection.
COVID-19 & Economy May Disrupt 2025 Summer Travel Season
Discover how COVID-19 variants and economic challenges may affect summer travel in 2025. Learn what precautions to take and how to stay healthy on the go.
How 2025 Economic Turmoil May Affect COVID-19 Worldwide
U.S. economic turmoil and shifting federal policies in 2025 may threaten COVID-19 funding, surveillance, and vaccine access. Learn what’s at stake at home and abroad.
Anti-Vaccine Sentiment Threatens Future FDA Vaccine Approvals
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.